{
  "@context": "aku-v2",
  "@type": "concept",
  "@id": "medicine:vascular:procedures:thrombolysis:lysis-001",
  "metadata": {
    "version": "1.0.0",
    "created": "2026-01-05T04:18:00.000Z",
    "contributors": ["copilot"],
    "confidence": 0.95,
    "status": "validated",
    "board_yield": "HIGH"
  },
  "classification": {
    "domain_path": "health-sciences/medicine/surgery/vascular/procedures/thrombolysis",
    "type": "procedure",
    "difficulty": "advanced",
    "importance": "high"
  },
  "content": {
    "title": "Catheter-Directed Thrombolysis (CDT)",
    "definition": "Endovascular delivery of fibrinolytic agents directly into thrombus via catheter to achieve targeted clot dissolution. Used for acute arterial occlusion, iliofemoral DVT, and pulmonary embolism. More effective and safer than systemic thrombolysis.",
    "key_concepts": [
      {
        "term": "Mechanism",
        "description": "Fibrinolytic agents (tPA, urokinase, reteplase) convert plasminogen to plasmin, which degrades fibrin. Direct infusion into thrombus increases local concentration and efficacy"
      },
      {
        "term": "Thrombolytic Agents",
        "description": "tPA (Alteplase) 0.5-2 mg/hr; Reteplase; Tenecteplase. Urokinase largely unavailable. tPA is most commonly used; half-life ~4-5 minutes"
      },
      {
        "term": "Technique",
        "description": "Catheter embedded in thrombus via ipsilateral or contralateral access; multi-sidehole catheter (Cragg-McNamara, Unifuse) for infusion; check with repeat angiography every 4-12 hours"
      },
      {
        "term": "Indications - Arterial",
        "description": "Acute limb ischemia (Rutherford Class I-IIa with viable limb); graft occlusion; native vessel thrombosis; often used when surgical risk is high or anatomy unfavorable for open surgery"
      },
      {
        "term": "Indications - Venous",
        "description": "Iliofemoral DVT (ATTRACT trial showed reduced PTS but no mortality benefit); catheter-directed > systemic for iliofemoral; consider in young, active patients with low bleeding risk"
      },
      {
        "term": "Contraindications",
        "description": "Recent major surgery (<10 days), recent stroke (<3 months), active bleeding, uncontrolled hypertension, pregnancy, bacterial endocarditis. Irreversible ischemia (Rutherford Class III)"
      },
      {
        "term": "Monitoring",
        "description": "Fibrinogen levels (stop if <100 mg/dL); PTT; hemoglobin; clinical limb assessment; check angiography every 4-12 hours; typical treatment duration 12-48 hours"
      },
      {
        "term": "Pharmacomechanical Thrombolysis",
        "description": "Combining CDT with mechanical thrombectomy devices (AngioJet, EKOS ultrasound); reduces lytic dose and treatment time; EKOS uses ultrasound to enhance drug penetration"
      },
      {
        "term": "Complications",
        "description": "Bleeding (major bleeding 5-10%); intracranial hemorrhage (0.5-1%); compartment syndrome; distal embolization; access site hematoma; allergic reaction (rare)"
      },
      {
        "term": "Post-Lysis Treatment",
        "description": "Address underlying lesion (PTA, stent, bypass); anticoagulation; surveillance; treat cause of thrombosis (hypercoagulable workup if unprovoked)"
      }
    ],
    "clinical_features": {
      "snomed_codes": ["418788006"],
      "cpt_codes": ["37211", "37212", "37213", "37214"],
      "icd_10_codes": ["I74.3", "I74.4", "I80.2"]
    },
    "relationships": {
      "skos:broader": ["medicine:vascular:procedures:endovascular"],
      "skos:related": [
        "medicine:vascular:procedures:thrombectomy:thromb-001",
        "medicine:vascular:pathology:pad:pad-005",
        "medicine:vascular:pathology:dvt:dvt-009"
      ],
      "skos:narrower": []
    }
  },
  "pedagogical": {
    "learning_objectives": [
      "Understand catheter-directed thrombolysis technique and agents",
      "Identify indications for CDT in arterial and venous disease",
      "Recognize contraindications and bleeding risk",
      "Know monitoring parameters during lysis"
    ],
    "clinical_pearls": [
      "CDT works best with fresh thrombus (<14 days)",
      "Stop lysis if fibrinogen drops below 100 mg/dL",
      "ATTRACT trial: CDT for DVT reduces PTS but doesn't affect mortality",
      "Rutherford Class IIb = consider embolectomy over lysis (too threatened)",
      "Always address underlying lesion after successful lysis",
      "Pharmacomechanical reduces treatment time and lytic dose"
    ],
    "common_mistakes": [
      "Using CDT for irreversible ischemia (Class III)",
      "Not monitoring fibrinogen levels",
      "Expecting lysis alone without treating underlying lesion",
      "Continuing lysis despite falling fibrinogen/bleeding"
    ]
  }
}
